Abstract
Genetic polymorphisms in drug-metabolizing enzymes, transporters, receptors, and other drug targets have been linked to interindividual differences in the efficacy and toxicity of many medications. Pharmacogenomic studies are rapidly elucidating the inherited nature of these differences in drug disposition and effects, thereby enhancing drug discovery and providing a stronger scientific basis for optimizing drug therapy on the basis of each patient's genetic constitution.
Keywords
PharmacogenomicsPharmacogeneticsDrugComputational biologyDrug discoveryDrug responseGenomicsPharmacologyFunctional genomicsBiologyPersonalized medicineMedicineBioinformaticsGeneticsGenomeGeneGenotype
Affiliated Institutions
Related Publications
Detecting Differentially Expressed Genes in Microarrays Using Bayesian Model Selection
AbstractDNA microarrays open up a broad new horizon for investigators interested in studying the genetic determinants of disease. The high throughput nature of these arrays, whe...
Publication Info
- Year
- 1999
- Type
- review
- Volume
- 286
- Issue
- 5439
- Pages
- 487-491
- Citations
- 2463
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
2463
OpenAlex
Cite This
William E. Evans,
Mary V. Relling
(1999).
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics.
Science
, 286
(5439)
, 487-491.
https://doi.org/10.1126/science.286.5439.487
Identifiers
- DOI
- 10.1126/science.286.5439.487